Strongly-Adhesive Hyaluronic Acid/ε-PL Aerogel for Rapid Hemostasis of Life-Threatening Arterial Bleeding and On-Demand Atraumatic Removal
Effective management of traumatic hemorrhage requires rapid blood loss control and facile removal of hemostatic materials to minimize secondary tissue damage. We fabricated a strongly adhesive aerogel (OPA) via Schiff-base crosslinking of oxidized hyaluronic acid (OHA) and ε-polylysine (ε-PL), enabling rapid hemostasis in lethal arterial trauma and on-demand removal via phase transition. OPAs exhibited tunable porosity and rapid blood absorption. Surface hydroxyl, amino, and carboxyl groups promoted strong hydrogen bonding with tissues, blood cells, and plasma proteins, enhancing tissue adhesion and platelet capture/activation. In a rabbit femoral-artery-injury model, OPA4 shortened hemostatic time by ~80% and reduced blood loss to 38% of the blank group. Notably, OPAs retained only 2% of initial adhesion after hydration, allowing gentle removal. OPAs also demonstrated excellent antibacterial activity, biocompatibility, and biodegradability. The simple one-step freeze-drying process and tailorable shapes offer scalable production and versatile applications. This study provides a versatile strategy for emergency and surgical hemostasis, combining rapid control of life-threatening arterial bleeding with on-demand atraumatic removal, promising improved patient outcomes and streamlined postoperative care.